Agios Pharmaceuticals AGIO
NASDAQ AGIO
$33.10 -0.03 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Agios Pharmaceuticals (AGIO) Cash from Discontinued Operations (2020 - 2021)

Agios Pharmaceuticals' (AGIO) quarterly Cash from Discontinued Operations came in at 4102000.0 in Q4 2021, down 335.48% YoY from 1742000.0 in Q4 2020, and up 60.24% on a QoQ basis from 10318000.0 in Q3 2021.

Analysis

Agios Pharmaceuticals (AGIO) Cash from Discontinued Operations (2020 - 2021) Analysis & Trends

Agios Pharmaceuticals (AGIO) has 2 years of Cash from Discontinued Operations data on file, last reported at 4102000.0 in Q4 2021.

  • Quarterly Cash from Discontinued Operations fell 335.48% year-over-year to 4102000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was 4102000.0 (up 95.31% YoY) and the FY2021 annual result came in at 93234000.0, down 99.15% from the prior year.
  • Cash from Discontinued Operations advanced to 4102000.0 in Q4 2021, from 10318000.0 in the prior quarter.
  • In the past five years, Cash from Discontinued Operations ranged from a high of 1742000.0 in Q4 2020 to a low of 48291000.0 in Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Agios Pharmaceuticals 1.97 Bn 1.97 Bn 41.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -4.10 Mn
Sep 30, 2021 -10.32 Mn
Jun 30, 2021 -48.29 Mn
Mar 31, 2021 -30.52 Mn
Dec 31, 2020 1.74 Mn
Sep 30, 2020 -11.59 Mn
Jun 30, 2020 -10.39 Mn
Mar 31, 2020 -26.58 Mn